Abstract:Abstract Background The intestinal immune system tolerates food antigens and the commensal microbiota to prevent chronic inflammation. Inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease, are characterized by the loss of tolerance towards the microbiota, leading to inflammation, which is characterized by the high production of cytokines such as TNF and the influx of macrophages and neutrophils to the gut. Tolerance is driven by tolerogenic dendritic cells (tolDCs). Currently, there is no cure for IBD and while available treatments may reduce symptoms, there are no pharmacological therapies that specifically seek to rescue tolerance. Inducing tolDCs in patients with IBD may be a promising therapy since it is a way to directly target the main cause of the disease. tolDCs have been defined by down-regulating TNF (pro-inflammatory cytokine), producing IL-10 (anti-inflammatory cytokine), and active oxidative phosphorylation (OXPHOS) in the mitochondria. Aims Given the tolDC characteristic of active OXPHOS, the objective of our project was to evaluate the role of PGC-1α, a major mediator of mitochondria biogenesis, in generating toDCs using murine bone marrow-derived dendritic cells (BMDC). Our hypothesis is that tolDCs would be (1) generated by pharmacological activation of PGC-1α by ZLN005, and (2) constrained by inhibition of PGC-1α by SR18292. Methods We treated BMDC cultures with ZLN005 (PGC-1α activator) or SR18292 (PGC-1α inhibitor), and LPS. We characterized the effect of PGC-1α manipulation on the metabolism of BMDCs by metabolomics and Seahorse XF Cell Mito Stress Test. In addition, we evaluated features of tolDCs, such as gene expression by qPCR, and cytokine production by ELISA. Results We observed that activation of PGC-1α altered the metabolic profile of BMDC, and upregulates genes known to be expressed in tolDCs. However, this transcriptional upregulation was lost after LPS stimulation and did not alter TNF or IL-10 levels in BMDCs. PGC-1α inhibition, on other hand, decreased features of tolDCs, such as metabolic profile, transcriptional activation, and the levels of LPS-induced IL-10. Our data suggest that PGC-1α activation with ZLN005 does not increase the generation of tolDCs in vitro. However, inhibition of PGC-1α with SR18292 constrains tolDCs generation. Conclusions PGC-1α is important for the development of tolDCs in murine dendritic cells. Funding Agencies NSERC and FRQNT

On the Role of T Lymphocytes in Stimulation of Humoral Immunity Induced by Peptidoglycan–Monomer Linked with Zinc

On the role of T lymphocytes in stimulation of humoral immunity induced by peptidoglycan-monomer linked with zinc

Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulation

Zinc supplementation induces regulatory T cells by inhibition of Sirt-1 deacetylase in mixed lymphocyte cultures

Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets

The Role of Zinc in GM-CSF-Induced Signaling in Human Polymorphonuclear Leukocytes

Evidence for the Modulation of the Immune Response in Peripheral Blood Mononuclear Cells after Stimulation with a High Molecular Weight β-glucan Isolated from Lactobacillus fermentum Lf2

GPR43 regulates marginal zone B‐cell responses to foreign and endogenous antigens

Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes

Effect of DON and ZEN and their metabolites DOM-1 and HZEN on B cell proliferation and antibody production

Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against Mycobacterium Tuberculosis Infection

Bacterial Polysaccharides with Zwitterionic Charge Motifs: Toll-Like Receptor 2 Agonists,T Cell Antigens, or Both?

A41 THE ROLE OF PGC-1α IN MURINE BONE MARROW DENDRITIC CELLS

Porcine B Cell Subset Responses to Toll-like Receptor Ligands

LPS Stimulates IgM Production in Vivo Without Help from Non-B Cells

Zinc Supplementation Plays a Crucial Role in T Helper 9 Differentiation in Allogeneic Immune Reactions and Non-Activated T Cells.

Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria

Gram-Positive Bacteria Cell Wall Peptidoglycan Polymers Activate Human Dendritic Cells to Produce IL-23 and IL-1β and Promote TH17 Cell Differentiation

Simultaneous Stimulation of Peripheral Blood Mononuclear Cells with CpG ODN2006 and α-IgM Antibodies Leads to Strong Immune Responses in Monocytes Independent of B Cell Activation

The radioprotective 105/MD-1 complex links TLR2 and TLR4/MD-2 in antibody response to microbial membranes

The Immunostimulatory Effects of CpG Oligonucleotide on Human Peripheral Blood B Lymphocyte